Výsledky vyhledávání - "Upadhyay, Ojesh R"

833. Efficacy and Safety of Long-Acting Cabotegravir + Rilpivirine in Participants with HIV/HCV Co-infection: ATLAS-2M 48-Week Results

Autor: D’Amico, Ronald, Benn, Paul, Thiagarajah, Shanker, Ford, Susan L, Birmingham, Eileen, Upadhyay, Ojesh R, Garside, Louise, Van Solingen-Ristea, Rodica, Vandermeulen, Kati, Spreen, William

Publikováno v: Open Forum Infectious Diseases

Background The phase IIIb ATLAS-2M study demonstrated non-inferiority of long-acting (LA) cabotegravir (CAB) + rilpivirine (RPV) dosed every 8 weeks (Q8W) compared with every 4 weeks (Q4W) for maintenance of virologic suppression. Hepatitis C virus (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29fe0ffefe1cc9ccfdbfa3371bbfa368
https://doi.org/10.1093/ofid/ofab466.1029

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání